Scientific Notes of V.I. Vernadsky Crimean Federal University. Biology. Chemistry Scientific Notes of V.I. Vernadsky Crimean Federal University. Biology. Chemistry Ученые записки Крымского федерального университета имени В.И. Вернадского. Биология. Химия. 2413-1725 91877 10.29039/2413-1725-2024-10-3-239-257 БИОЛОГИЧЕСКИЕ НАУКИ BIOLOGICAL SCIENCES БИОЛОГИЧЕСКИЕ НАУКИ THE CORRECTION BY ARGININE, MODERATE PHYSICAL ACTIVITY AND THEIR COMBINATION OF SKELETAL MUSCLE CONTRACTIVE FUNCTION DISTURBANCES` FOR STEROID MYOPATHY IN EXPERIMENTS ON RATS КОРРЕКЦИЯ АРГИНИНОМ, УМЕРЕННОЙ ФИЗИЧЕСКОЙ НАГРУЗКОЙ И ИХ КОМБИНАЦИЕЙ НАРУШЕНИЙ СОКРАТИТЕЛЬНОЙ ФУНКЦИИ СКЕЛЕТНОЙ МЫШЦЫ ПРИ СТЕРОИДНОЙ МИОПАТИИ В ЭКСПЕРИМЕНТАХ НА КРЫСАХ Труш В. В. Trush V. V. Соболев В. И. Sobolev V. I. Попов М. Н. Popov M. N. Донецкий государственный университет Россия Донецкий государственный университет Russian Federation Крымский федеральный университет имени В.И.Вернадского Crimean Federal University of a name of V.I.Vernadsky 12 12 2024 12 12 2024 10 3 239 257 12 12 2024 https://sn-biolchem.cfuv.ru/korrekcziya-argininom-umerennoj-fizicheskoj-nagruzkoj-i-ih-kombinacziej-narushenij-sokratitelnoj-funkczii-skeletnoj-myshczy-pri-steroidnoj-miopatii-v-eksperimentah-na-krysah/

В экспериментах на крысах изучали эффективность аргинина (АРГ, 100 мг/кг/сутки), умеренной динамической физической нагрузки (ФН) и их комбинации в компенсации расстройств сократительной функции m. tibialis anterior, вызванных введением дексаметазона (ДМ, 0,25 мг/кг/1 раз в 2-е суток, в течение 10–60 дней). Установлено, что АРГ, ФН и их комбинация, используемые в комплексе с ДМ, предотвратили характерное для ДМ-групп ухудшение резистентности мышцы к утомлению, но неоднозначно сказывались на сократительных и эргометрических ее параметрах: АРГ полностью компенсировал их ухудшение, вызванное ДМ; спустя первые 10 дней применения ДМ с ФН наблюдалось ухудшение амплитудных и временных параметров сокращения мышцы, тогда как по завершении 2-месячного периода – их нормализация. АРГ, применяемый в комплексе с ФН и ДМ, предотвратил типичное для ДМ+ФН-групп ухудшение амплитудных, но не временных параметров сокращения СМ.

The aim of the research was to study the effectiveness of the arginine (ARG, 100 mg/kg/day), moderate dynamic physical activity (FA) and their combination in compensating of impaired contractile function of m. tibialis anterior, caused by the administration of dexamethasone (DM, 0,25 mg / kg / 2 days, for 10 to 60 days), were studied in experiments on rats. Methods. The experiments were held on young female rats (195–205 g), divided into 5 groups: control (n=10, C-group), the I-st experienced (n=30, received dexamethasone, DM-group), the II-nd experienced (n=30, received DM and daily swimming, DM+FA-group), III-rd experienced (n=30, received DM in combination with ARG, DM+ARG-group) and IV-th experienced (n=30, received DM in combination with ARG and daily swimming, DM+ARG+FA-group). Each experimental group was divided into 3 groups (n=10 in each) depending on the duration of the experimental exposure (10, 30 and 60 days). Dexamethasone (KRKA, Slovenia) was administered at a dose of 0,25 mg/kg, once in 2 days, intraperitoneally, arginine («Cardioarginine», «Zdorovye», Ukraine) – daily, subcutaneously, at a dose of 100 mg/kg. Animals of DM+FA- and DM+ARG+FA-groups began to be subjected to physical activity from the 1-st day of medications administration, daily until the end of their administration periods. FA was modeled by swimming at a comfortable temperature (37 ± 1°C) at an arbitrary speed without additional weights, gradually increasing its duration from 5 to 60 minutes per day. On anesthetized animals (sodium thiopental, 100 mg/kg), the parameters of the functional state of m. tibialis anterior under different modes of its contractions, using myography and ergography were studied during stimulation of the peroneal nerve with superthreshold electric current. Results. ARG, FA and their combination, used with DM, prevented the deterioration of skeletal muscle (SM) resistance to fatigue, which is characteristic for DM-groups, and even led to an elongation (p<0.05 relative to control) of maximum (all these factors) and submaximal (arginine or its combination with swimming) periods of SM performance at certain stages of experimental exposure. The use of the arginine, moderate FA and their combination, used with DM, had an ambiguous effect on the contractile parameters of the SM. ARG completely compensated the deterioration of the parameters of single and tetanic SM contractions caused by DM. In case of DM`s use in combination with FA, the change in the contractile parameters of the SM in the dynamics of the 2-month period of experimental exposure was of a phase nature: at the initial stages (10 days after) they worsened, while at the end of the 2-month period, they were normalized and the absolute force of tetanic contraction was even increased (p<0,05 relative to control). ARG, used in combination with FA and DM, prevented the deterioration in muscle contractile parameters typical for DM+FA-groups after the first 10–30 days of exposure, and at the end of the 60-day period of exposure, it led to an improvement of its ergometric parameters (p<0,05 relative to control). Use in combination with DM the arginine, moderate FA and their combination, used with DM, had an ambiguous effect on the speed parameters of the SM`s contraction: ARG prevented the deterioration of the contraction`s speed parameters, while in case of DM`s use with FA or the combination «FA+ARG», their deterioration was noted. Conclusion. ARG ensured full compensation of disorders of the SM`s contractile function caused by the DM`s administration. Moderate FA and its combination with ARG caused a deterioration of the SM contraction`s speed parameters on the background of an initial deterioration of its single and tetanic contractions` parameters among animals of the DM+FA-group. The results obtained cast doubt on the effectiveness of moderate aerobic physical activity to maintain fast muscles` normal functional parameters during glucocorticoid therapy. At the same time, in case of FA`s use in combination with glucocorticoid therapy, it is advisable to additionally administrate moderate pharmacological doses of the ariginine for better tolerability of skeletal muscles to FA.

 скелетная мышца дексаметазон стероидная миопатия аргинин физическая нагрузка крысы skeletal muscle dexamethasone steroid myopathy arginine physical activity rats

Chang J. S., Kong I. D., Irisin prevents dexamethasone-induced atrophy in C2C12 myotubes, Pflugers Arch., 472, 495 (2020). DOI: https://doi.org/10.1007/s00424-020-02367-4 Chang J. S., Kong I. D., Irisin prevents dexamethasone-induced atrophy in C2C12 myotubes, Pflugers Arch., 472, 495 (2020). DOI: https://doi.org/10.1007/s00424-020-02367-4 Park S. H., Oh J., Jo M., Kim J. K., Kim D. S., Kim H. G., Yoon K., Yang Y., Geum J. H., Kim J. E., Choi S. Y., Kim J. H., Cho J. Y., Water Extract of Lotus Leaf Alleviates Dexamethasone-Induced Muscle Park S. H., Oh J., Jo M., Kim J. K., Kim D. S., Kim H. G., Yoon K., Yang Y., Geum J. H., Kim J. E., Choi S. Y., Kim J. H., Cho J. Y., Water Extract of Lotus Leaf Alleviates Dexamethasone-Induced Muscle Adhikary S., Choudhary D., Tripathi A. K., Karvande A., Ahmad N., Kothari P., Trivedi R., FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects Adhikary S., Choudhary D., Tripathi A. K., Karvande A., Ahmad N., Kothari P., Trivedi R., FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects Kim H., Jang M., Park R., Jo D., Choi I., Choe J., Oh W. K., Park J., Conessine Treatment Reduces Dexamethasone-Induced Muscle Atrophy by Regulating MuRF1 and Atrogin-1 Expression, J. Microbiol. Kim H., Jang M., Park R., Jo D., Choi I., Choe J., Oh W. K., Park J., Conessine Treatment Reduces Dexamethasone-Induced Muscle Atrophy by Regulating MuRF1 and Atrogin-1 Expression, J. Microbiol. Archer-Lahlou E., Lan C., Jagoe R. T., Physiological culture conditions alter myotube morphology and responses to atrophy treatments: implications for in vitro research on muscle wasting, Physiol. Rep., 6, e13726 Archer-Lahlou E., Lan C., Jagoe R. T., Physiological culture conditions alter myotube morphology and responses to atrophy treatments: implications for in vitro research on muscle wasting, Physiol. Rep., 6, e13726 Grishin S. N., Gabdrakhmanov A. I., Khairullin A. E., Ziganshin A. U., The Influence of Glucocorticoids and Catecholamines on the Neuromuscular Transmission, Biologicheskie membrany (Biological Grishin S. N., Gabdrakhmanov A. I., Khairullin A. E., Ziganshin A. U., The Influence of Glucocorticoids and Catecholamines on the Neuromuscular Transmission, Biologicheskie membrany (Biological Kamaliev R. R., Grishin S. N., Falou Zh. Yu., Ziganshin A. U., The effect of hydrocortisone, ATP and adenosine on rat skeletal muscle contraction, Kazanskiy meditsinskiy zhurnal (Kazan Medical Journal), 90, 556 Kamaliev R. R., Grishin S. N., Falou Zh. Yu., Ziganshin A. U., The effect of hydrocortisone, ATP and adenosine on rat skeletal muscle contraction, Kazanskiy meditsinskiy zhurnal (Kazan Medical Journal), 90, 556 Langendorf E. K., Rommens P. M., Drees P., Mattyasovszky S. G., Ritz U., Detecting the Effects of the Glucocorticoid Dexamethasone on Primary Human Skeletal Muscle Cells-Differences to the Murine Cell Line, Langendorf E. K., Rommens P. M., Drees P., Mattyasovszky S. G., Ritz U., Detecting the Effects of the Glucocorticoid Dexamethasone on Primary Human Skeletal Muscle Cells-Differences to the Murine Cell Line, Macedo A. G., Krug A. L., Souza L. M., Martuscelli A. M., Constantino P. B., Zago A. S., Rush J. W. E., Santos C. F., Amaral S. L., Time-course changes of catabolic proteins following muscle atrophy Macedo A. G., Krug A. L., Souza L. M., Martuscelli A. M., Constantino P. B., Zago A. S., Rush J. W. E., Santos C. F., Amaral S. L., Time-course changes of catabolic proteins following muscle atrophy Cai X., Yuan Y., Liao Z., Xing K., Zhu C., Xu Y., Yu L., Wang L., Wang S., Zhu X., Gao P., Zhang Y., Jiang Q., Xu P., Shu G., α-Ketoglutarate prevents skeletal muscle protein degradation and muscle Cai X., Yuan Y., Liao Z., Xing K., Zhu C., Xu Y., Yu L., Wang L., Wang S., Zhu X., Gao P., Zhang Y., Jiang Q., Xu P., Shu G., α-Ketoglutarate prevents skeletal muscle protein degradation and muscle Lomonosova Yu. N., Shenkman B. S., Nemirovskaya T. L., Signal effects of substrate stimulation of nNOS in rat skeletal muscle after eccentric exercise, Doklady akademii nauk (Reports of the Academy of Lomonosova Yu. N., Shenkman B. S., Nemirovskaya T. L., Signal effects of substrate stimulation of nNOS in rat skeletal muscle after eccentric exercise, Doklady akademii nauk (Reports of the Academy of Safdar A., Little J. P., Stokl A. J., Hettinga B. P., Akhtar M., Tarnopolsky M. A., Exercise Increases Mitochondrial PGC-1a Content and Promotes Nuclear-Mitochondrial Crosstalk to Coordinate Mitochondrial Safdar A., Little J. P., Stokl A. J., Hettinga B. P., Akhtar M., Tarnopolsky M. A., Exercise Increases Mitochondrial PGC-1a Content and Promotes Nuclear-Mitochondrial Crosstalk to Coordinate Mitochondrial Vladimirsky V. E., Vladimirsky E. V., Lunina A. N., Fesyun A. D., Rachin A. P., Lebedeva O. D., Yakovle M. YU., Tubekova (Ansokova) M. A., Molecular mechanisms of adaptive and therapeutic Vladimirsky V. E., Vladimirsky E. V., Lunina A. N., Fesyun A. D., Rachin A. P., Lebedeva O. D., Yakovle M. YU., Tubekova (Ansokova) M. A., Molecular mechanisms of adaptive and therapeutic Boger R. H., Bode-Boger S. M., The clinical pharmacology of L-arginine, Annu. Rev. Pharmacol. Toxicol., 41, 79 (2001). DOI: https://doi.org/10.1146/annurev.pharmtox.41.1.79 Boger R. H., Bode-Boger S. M., The clinical pharmacology of L-arginine, Annu. Rev. Pharmacol. Toxicol., 41, 79 (2001). DOI: https://doi.org/10.1146/annurev.pharmtox.41.1.79 Cabrales P., Tsai A. G., Intaglietta M., Exogenous nitric oxide induces protection during hemorrhagic shock, Resuscitation, 80, 707 (2009). DOI: https://doi.org/10.1016/j.resuscitation.2009.03.001 Cabrales P., Tsai A. G., Intaglietta M., Exogenous nitric oxide induces protection during hemorrhagic shock, Resuscitation, 80, 707 (2009). DOI: https://doi.org/10.1016/j.resuscitation.2009.03.001 Gorini G., Gamberi T., Fiaschi T., Mannelli M., Modesti A., Magherini F., Irreversible plasma and muscle protein oxidation and physical exercise, Free Radic. Res., 53, 126 (2019). Gorini G., Gamberi T., Fiaschi T., Mannelli M., Modesti A., Magherini F., Irreversible plasma and muscle protein oxidation and physical exercise, Free Radic. Res., 53, 126 (2019). Sagidova S. A., Influence physical activities on near-limit of free radical oxidation and reactivity microvascular in myocardium, Nauka i sport: sovremennye tendencii (Science and sport: current Sagidova S. A., Influence physical activities on near-limit of free radical oxidation and reactivity microvascular in myocardium, Nauka i sport: sovremennye tendencii (Science and sport: current Geng H., Song Q., Cheng Y., Li H., Yang R., Liu S., Hao L., MicroRNA 322 Aggravates Dexamethasone-Induced Muscle Atrophy by Targeting IGF1R and INSR, Int. J. Mol. Sci., 21, 1111 Geng H., Song Q., Cheng Y., Li H., Yang R., Liu S., Hao L., MicroRNA 322 Aggravates Dexamethasone-Induced Muscle Atrophy by Targeting IGF1R and INSR, Int. J. Mol. Sci., 21, 1111 Gunina L., The mechanisms of effects of antioxidants on the physical performance of athletes, Nauka v olimpijskom sporte (Science in Olympic sports), 1, 25 (2016). Gunina L., The mechanisms of effects of antioxidants on the physical performance of athletes, Nauka v olimpijskom sporte (Science in Olympic sports), 1, 25 (2016). Park M. Y., Jeong Y. J., Kang G. C., Kim M.-H., Kim S. H., Chung H.-J., Jung J. Y., Kim W. J., Nitric oxide-induced apoptosis of human dental pulp cells is mediated by the mitochondria-dependent pathway, Korean Park M. Y., Jeong Y. J., Kang G. C., Kim M.-H., Kim S. H., Chung H.-J., Jung J. Y., Kim W. J., Nitric oxide-induced apoptosis of human dental pulp cells is mediated by the mitochondria-dependent pathway, Korean Katzung B.G. Greenspan's Basic and Clinical Pharmacology. B.G. Katzung (ed.). 14th ed. New York: McGraw-Hill Medical; 2018. Katzung B.G. Greenspan's Basic and Clinical Pharmacology. B.G. Katzung (ed.). 14th ed. New York: McGraw-Hill Medical; 2018. Shekunova E. V., Kovaleva M. A., Makarova M. N., Makarov V. G., Dose selection in preclinical studies: cross-species dose conversion, Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo Shekunova E. V., Kovaleva M. A., Makarova M. N., Makarov V. G., Dose selection in preclinical studies: cross-species dose conversion, Vedomosti Nauchnogo tsentra ekspertizy sredstv meditsinskogo Bger R. H., The Pharmacodynamics of L-Arginine, J. Nutr., 137, 1650 (2007). DOI: https://doi.org/10.1093/jn/137.6.1650s Bger R. H., The Pharmacodynamics of L-Arginine, J. Nutr., 137, 1650 (2007). DOI: https://doi.org/10.1093/jn/137.6.1650s Wu G., Morris S. M. Jr., Arginine metabolism: nitric oxide and beyond, Biochem. J., 336, 1 (1998). DOI: https://doi.org/10.1042/bj3360001 Wu G., Morris S. M. Jr., Arginine metabolism: nitric oxide and beyond, Biochem. J., 336, 1 (1998). DOI: https://doi.org/10.1042/bj3360001 Karimova R. G., Bilalov I. N., Garipov T. V., Activization of nitric oxide formation in the rats organism by different factors, Fundamental'nyye issledovaniya (Basic Research), 2, 53 (2015). (In Russ.) Karimova R. G., Bilalov I. N., Garipov T. V., Activization of nitric oxide formation in the rats organism by different factors, Fundamental'nyye issledovaniya (Basic Research), 2, 53 (2015). (In Russ.) Zhelnin Y. V., Zvyagintseva T. V, Kryvoshapka O. V., ost-traumatic regeneration of the alveolar bone and its relation to the nitric oxide metabolites in rats with glucocorticoid osteoporosis, Uspekhi Zhelnin Y. V., Zvyagintseva T. V, Kryvoshapka O. V., ost-traumatic regeneration of the alveolar bone and its relation to the nitric oxide metabolites in rats with glucocorticoid osteoporosis, Uspekhi Dreval A. V., Komeredus I. V., Budul N. A., Britvin T. A., Terpigorev S. A., Kabanova T. G., Chekanova A. V., Manifestations of hypercorticism in patients on the background of a short course of systemic Dreval A. V., Komeredus I. V., Budul N. A., Britvin T. A., Terpigorev S. A., Kabanova T. G., Chekanova A. V., Manifestations of hypercorticism in patients on the background of a short course of systemic Elin R. J., Magnesium metabolism in health and disease, Disease-a-Month, 34, 166 (1988). DOI: https://doi.org/10.1016/0011-5029(88)90013-2 Elin R. J., Magnesium metabolism in health and disease, Disease-a-Month, 34, 166 (1988). DOI: https://doi.org/10.1016/0011-5029(88)90013-2 Nishida H., Ikegami A., Kaneko C., Kakuma H., Nishi H., Tanaka N., Aoyama M., Usami M., Okimura Y., Dexamethasone and BCAA Failed to Modulate Muscle Mass and mTOR Signaling in GH-Deficient Rats, Nishida H., Ikegami A., Kaneko C., Kakuma H., Nishi H., Tanaka N., Aoyama M., Usami M., Okimura Y., Dexamethasone and BCAA Failed to Modulate Muscle Mass and mTOR Signaling in GH-Deficient Rats, Korkushko O. V., Duzhak H. V., Shatylo V. B., Bondarenko Ye. V., Nedbailo A. V., Study of Kardioarginin – Zdorovia Effect on Motor Function of Vascular Endothelium in Patients with Hypertension Korkushko O. V., Duzhak H. V., Shatylo V. B., Bondarenko Ye. V., Nedbailo A. V., Study of Kardioarginin – Zdorovia Effect on Motor Function of Vascular Endothelium in Patients with Hypertension Danese E., Lippi G., Sanchis-Gomar F., Brocco G., Rizzo M., Banach M., Montagnana M., Physical Exercise and DNA Injury: Good or Evil? Adv. Clin. Chem., 81, 193 (2017). Danese E., Lippi G., Sanchis-Gomar F., Brocco G., Rizzo M., Banach M., Montagnana M., Physical Exercise and DNA Injury: Good or Evil? Adv. Clin. Chem., 81, 193 (2017). Voltarelli F. F., Gobatto C. A., de Mello M. A. R., Minimun blood lactate and muscle protein of rats during swimming exercise, Biol. Sport., 25, 23 (2008). Voltarelli F. F., Gobatto C. A., de Mello M. A. R., Minimun blood lactate and muscle protein of rats during swimming exercise, Biol. Sport., 25, 23 (2008). Trush V. V., Sobolev V. I., Efficiency of alphacalcidol in compensation of disorders of contractile functions of the skeletal muscle with dexamethazone hypercorticism in experiments on rats, Uchenyye Trush V. V., Sobolev V. I., Efficiency of alphacalcidol in compensation of disorders of contractile functions of the skeletal muscle with dexamethazone hypercorticism in experiments on rats, Uchenyye Trush V. V., Sobolev V. I., Influence of long dexamethasone administration on electrophysiological parameters of the rat skeletal muscle at rest and exhaustion development, Eksperimental'naya i Trush V. V., Sobolev V. I., Influence of long dexamethasone administration on electrophysiological parameters of the rat skeletal muscle at rest and exhaustion development, Eksperimental'naya i Trush V. V., Sobolev V. I., Alphaalcidol modulation of the dexamethazone effects on parameters of M-response of skeletal muscle of white rats, Pathological Physiology and Experimental Therapy, 65, 53 Trush V. V., Sobolev V. I., Alphaalcidol modulation of the dexamethazone effects on parameters of M-response of skeletal muscle of white rats, Pathological Physiology and Experimental Therapy, 65, 53 Uchikawa K., Takahashi H., Hase K., Masakado Y., Liu M., Strenuous exercise-induced alterations of muscle fiber cross-sectional area and fiber-type distribution in steroid myopathy rats, Am. J. Phys. Med. Uchikawa K., Takahashi H., Hase K., Masakado Y., Liu M., Strenuous exercise-induced alterations of muscle fiber cross-sectional area and fiber-type distribution in steroid myopathy rats, Am. J. Phys. Med.